Assertio Therapeutics, Inc. (ASRT): Price and Financial Metrics

Assertio Therapeutics, Inc. (ASRT): $3.15

0.02 (+0.64%)

POWR Rating

Component Grades













ASRT Stock Summary

  • Over the past twelve months, ASRT has reported earnings growth of -132.67%, putting it ahead of merely 14.2% of US stocks in our set.
  • In terms of volatility of its share price, ASRT is more volatile than 93.27% of stocks we're observing.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for ASRT comes in at -29.1% -- higher than that of only 13.58% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to Assertio Holdings Inc, a group of peers worth examining would be WRLD, EEX, AP, BRP, and ACEL.
  • ASRT's SEC filings can be seen here. And to visit Assertio Holdings Inc's official web site, go to

ASRT Valuation Summary

  • In comparison to the median Healthcare stock, ASRT's EV/EBIT ratio is 105.8% lower, now standing at -1.7.
  • Over the past 243 months, ASRT's price/earnings ratio has gone up 3.6.
  • Over the past 243 months, ASRT's EV/EBIT ratio has gone up 3.

Below are key valuation metrics over time for ASRT.

Stock Date P/S P/B P/E EV/EBIT
ASRT 2021-08-31 0.4 0.5 -1.1 -1.7
ASRT 2021-08-30 0.4 0.5 -1.1 -1.7
ASRT 2021-08-27 0.4 0.5 -1.1 -1.7
ASRT 2021-08-26 0.4 0.5 -1.0 -1.6
ASRT 2021-08-25 0.4 0.5 -1.0 -1.6
ASRT 2021-08-24 0.4 0.5 -1.0 -1.6

ASRT Growth Metrics

    The year over year cash and equivalents growth rate now stands at -42.41%.
  • Its 2 year revenue growth rate is now at -54.02%.
  • Its 3 year cash and equivalents growth rate is now at -39.72%.
Over the past 70 months, ASRT's revenue has gone down $304,297,000.

The table below shows ASRT's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 111.014 5.523 -1.281
2021-09-30 107.86 -4.59 -30.241
2021-06-30 116.953 -23.675 -44.5
2021-03-31 112.197 -44.735 -64.83
2020-12-31 106.275 -65.572 -28.144
2020-09-30 135.325 -51.735 -196.417

ASRT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ASRT has a Quality Grade of C, ranking ahead of 35.61% of graded US stocks.
  • ASRT's asset turnover comes in at 0.367 -- ranking 129th of 680 Pharmaceutical Products stocks.
  • NOVN, ARWR, and RIOT are the stocks whose asset turnover ratios are most correlated with ASRT.

The table below shows ASRT's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.367 0.819 -1.136
2021-03-31 0.343 0.800 -1.673
2020-12-31 0.354 0.813 -0.761
2020-09-30 0.380 0.884 -1.944
2020-06-30 0.337 0.927 -1.098
2020-03-31 0.332 0.957 -0.485

ASRT Price Target

For more insight on analysts targets of ASRT, see our ASRT price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $6.20 Average Broker Recommendation 1.5 (Moderate Buy)

ASRT Stock Price Chart Interactive Chart >

Price chart for ASRT

ASRT Price/Volume Stats

Current price $3.15 52-week high $3.52
Prev. close $3.13 52-week low $0.85
Day low $2.98 Volume 1,051,500
Day high $3.22 Avg. volume 947,349
50-day MA $2.64 Dividend yield N/A
200-day MA $1.87 Market Cap 143.11M

Assertio Therapeutics, Inc. (ASRT) Company Bio

Assertio Therapeutics, Inc. (formerly DepoMed) develops products for pain and other central nervous system conditions in the United States. The company was founded in 1995 and is focused in Newark, California.

ASRT Latest News Stream

Event/Time News Detail
Loading, please wait...

ASRT Latest Social Stream

Loading social stream, please wait...

View Full ASRT Social Stream

Latest ASRT News From Around the Web

Below are the latest news stories about Assertio Holdings Inc that investors may wish to consider to help them evaluate ASRT as an investment opportunity.

Is Assertio (ASRT) Stock Outpacing Its Medical Peers This Year?

Here is how Assertio (ASRT) and Homology Medicines (FIXX) have performed compared to their sector so far this year.

Yahoo | February 21, 2022

36 of the Best Ideas Companies to Present at the 2nd Annual Winter Wonderland Virtual Investor Conference on February 8th - 11th, 2022

RALEIGH, NC / ACCESSWIRE / January 28, 2022 / The Winter Wonderland Best Ideas Virtual Investor Conference will take place on February 8th \- 11th, 2022, where 36 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience.The virtual conference begins on Tuesday, February 8th, 2022, with company presentations beginning at 8:30 am Eastern Time.

Yahoo | January 28, 2022

Thinking about buying stock in Exterran Corp, Microbot Medical, Nordstrom, Telefonica S.A., or Assertio Holdings?

NEW YORK , Jan. 24, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for EXTN, MBOT, JWN, TEF, and ASRT. Full story available on

Benzinga | January 24, 2022

Assertio''s Digital Strategy Looks To Be Paying Off

No summary available.

Seeking Alpha | January 21, 2022

Sidoti Winter Virtual Small Cap Investor Conference

* Presentation Times and Weblinks Released for Over 70 Presenting Companies * Wednesday and Thursday, January 19th-20th, 2022NEW YORK, NY / ACCESSWIRE / January 18, 2022 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day January Small Cap Virtual Conference taking place Wednesday and Thursday, January 19th-20th, 2022. The links can also be found at www.

Yahoo | January 18, 2022

Read More 'ASRT' Stories Here

ASRT Price Returns

1-mo 20.23%
3-mo 27.02%
6-mo 138.64%
1-year 111.41%
3-year -76.97%
5-year -92.24%
YTD 44.50%
2021 52.40%
2020 -71.39%
2019 -65.37%
2018 -55.16%
2017 -55.33%

Continue Researching ASRT

Here are a few links from around the web to help you further your research on Assertio Therapeutics Inc's stock as an investment opportunity:

Assertio Therapeutics Inc (ASRT) Stock Price | Nasdaq
Assertio Therapeutics Inc (ASRT) Stock Quote, History and News - Yahoo Finance
Assertio Therapeutics Inc (ASRT) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8523 seconds.